Immunotherapy is well tolerated in Head and Neck Cancer

Tanguy Seiwert, MD of the University of Chicago discusses Immunotherapy and how it is well tolerated in Head and Neck Cancer at Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.

www.scrippshealth.org/cancer